TipRanks
Go Ultimate55% OFF

elexxion AG (E8X) AI Stock Analysis

DE:E8X

elexxion AG

(Munich:E8X)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Negative Factors

elexxion AG (E8X) vs. iShares MSCI Germany ETF (EWG)

-100%-75%-50%-25%0%25%DE:E8X-91.03%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 1.06M
Dividend Yield
―
Average Volume (3M)
5,703
Price to Earnings (P/E)
-1.4
Beta (1Y)
-0.28
Revenue Growth
―
EPS Growth
―
Country
Germany
Employees
9
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

elexxion AG Business Overview & Revenue Model

Company Description

elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. The company offers dental diode lasers under the elexxion pico, elexxion nano, and elexxion claros names; and elexxion pico lite, a so...

elexxion AG Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:E8X against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:EUZDE:EUZ69NeutralEUR 832.23M16.6319.49%1.65%4.42%35.68%
DE:DRW3DE:DRW365NeutralEUR 1.64B11.2810.20%2.23%5.06%40.18%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
DE:GMEDE:GME51NeutralEUR 11.71M-15.40-4.38%4.65%1.58%-148.73%
DE:AAQ1DE:AAQ140UnderperformEUR 21.34M-7.44-32.36%―1.81%42.09%

* Healthcare Sector Average

Performance Comparison

-50%0%50%DE:E8XDE:AAQ1DE:DRW3DE:EUZDE:GMEDE:PHH2Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:E8X and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:E8Xelexxion AG0.01-0.13-90.71%
DE:AAQ1aap Implantate1.45-0.01-0.68%
DE:DRW3Draegerwerk AG & Co. KGaA102.0031.8245.34%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik13.30-3.09-18.88%
DE:GMEGeratherm Medical2.15-1.52-41.40%
DE:PHH2PAUL HARTMANN AG188.50-31.61-14.36%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.